Company: ATHE
Filing Date: 2025-08-29
Form Type: 20-F
Source: 0001213900-25-082027
Chunk: 83

Company: ALTERITY THERAPEUTICS LTD
Filing Date: 2025-08-29
Form: 20-F
Item: Item 6
Chunk 83
---
 or less than the weighted average price at which our shares are traded on the Australian Securities Exchange during the 5 days up to and including the grant date or such other exercise price that the Remuneration Committee determines to be appropriate under the circumstances.

The plan rules contain a restriction on removing the ‘at risk’ aspect of the instruments granted to executives. Plan participants may not enter any transaction designed to remove the ‘at risk’ aspect of an instrument before it vests.

*                                          As of June 30, 2025, 170,000,000 options over ordinary shares                                       
        were issued to the directors during the current financial year, separate to the 2004 ASX Plan, following approval of the resolutions   
    to issue same at the AGM in November 2024. The value per option in the table above is at 30 September 2024, as approved by the shareholders
        at the AGM in November 2024. There were no options over ordinary shares issued as remuneration to any other key management personnel   
                                        of our Group during the current financial year (2024: 120,000,000).                                    
-----------------------------------------------------------------------------------------------------------------------------------------------

No ordinary shares were issued as a result of exercise of remuneration options by Directors and Key Management Personnel of Alterity Therapeutics Limited during the current or previous financial year.

50

d)   Key management personnel disclosure
----------------------------------------

Options and right holdings

The number of options over ordinary shares of our Group held during the financial year by each Director of Alterity Therapeutics Limited and other Key Management Personnel of our Group, including their personally related parties, are set out below:

Share Options of the Group        Balance             Granted as             Options                  Other               Balance                Total                Total      
                                  July 1,            Remuneration            Expired              movements (1)           June 30,             Vested and            Unvested    
                                    2024                 No.                   No.                                          2025              Exercisable            June 30,    
                                    No.                                                                                     No.                 June 30,               2025      
                                                                                                                                                  2025                 No.       
                                                                                                                                                  No.                            
---------------------------------------------------------------------------------------------------------------------------------------------------------------------------------
Mr. Geoffrey Kempler                14,000,000             60,000,000                   -                        -           74,000,000            74,000,000          -         
Mr. Lawrence Gozlan                  7,000,000             50,000,000                   -                1,